oral vs subq semaglutide Real-world use of versus subcutaneous in a cohort of type 2 diabetic patients: which option to which patient? | Journal of Endocrinological Investigation oral vs subq semaglutide stayinformedwithinpharmd

GLP-1 Agonist Basics GLP-1 (glucagon-like peptide-1) is a gutderived hormone that stimulates insulin release when blood sugar rises

Helping the body fight against infections

Which foods/sources contain it

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials

These medications are contraindicated in patients with: Personal history of medullary thyroid carcinoma Family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) For patients with standard hypothyroidism (typically autoimmune thyroiditis or post-ablation), these contraindications do not apply

Your optimal dose depends on factors including your starting weight, metabolic rate, gastrointestinal tolerance, and how your specific genetic pathways respond to GLP-1 receptor activation